コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 a-lipoic acid prevented the reduction in SCG creatine phosphate.
2 m, and increased the intracellular stores of creatine phosphate.
3 s a stimulatory role and processing requires creatine phosphate.
5 in p50 and attenuated the decline in cardiac creatine phosphate/adenosine triphosphate (PCr/ATP), per
6 onophosphate by the use of adenylate kinase, creatine phosphate, and creatine kinase in a single step
8 in glucose, upper glycolytic intermediates, creatine phosphate, and the amino acids glutamine and se
9 by changes in whole-tissue concentrations of creatine phosphate ATP, or AMP, but they leave open the
10 showed reduced cardiac function and reduced creatine phosphate:ATP (16% reduction), but ssTnI TAC he
12 mitochondrial capacity using the changes in creatine phosphate concentration ([PCr]) and pH as detec
13 city estimates on the kinetics of changes in creatine phosphate content ([PCr]) during recovery from
14 ely, high [MgATP]/low [MgADP] [10 mM MgATP + creatine phosphate (CP) + creatine kinase (CK)] or low [
17 ac muscles, the effects of ATP, ADP, Pi, and creatine phosphate (CP) on the rate of force redevelopme
18 reatine phosphokinase and ATPase activities, creatine phosphate (CP) was, surprisingly, found to be s
23 asma was inhibited by aspirin, ADP scavenger creatine phosphate/creative phosphokinase (CP/CPK), and
25 ing mitochondrial metabolism and cytoplasmic creatine-phosphate energy stores, completing the packagi
26 ared with reported 31P NMR analyses of total creatine phosphate flux to estimate that each creatine p
27 ithin the intermembrane space in the form of creatine phosphate, (ii) is prevented by the outer mitoc
30 reatine phosphate flux to estimate that each creatine phosphate molecule produced undergoes about 50
31 th changes in whole-tissue concentrations of creatine phosphate or adenine nucleotides; however, it d
33 The myocardial concentrations of ATP and creatine phosphate (PCr) and the rate of ATP synthesis t
36 on was also inhibited by the creatine kinase/creatine phosphate system that removes ADP from the chan
37 thickening while favoring higher myocardial creatine phosphate to creatine ratios (0.14 +/- 0.03 vs.
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。